Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China
· Delayed Price · Currency is CNY 17.41
+0.24 (1.40%)
Apr 24, 2025, 3:04 PM CST
SHE:002932 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 349.18 | 749.49 | 10,530 | 2,830 | 959.1 | 181.16 | Upgrade
|
| Other Revenue | 0.05 | 0.05 | - | - | - | - | Upgrade
|
| Revenue | 349.23 | 749.54 | 10,530 | 2,830 | 959.1 | 181.16 | Upgrade
|
| Revenue Growth (YoY) | -90.53% | -92.88% | 272.12% | 195.05% | 429.43% | 2.71% | Upgrade
|
| Cost of Revenue | 94.75 | 309.72 | 3,992 | 707.41 | 209.97 | 47.22 | Upgrade
|
| Gross Profit | 254.47 | 439.82 | 6,538 | 2,122 | 749.13 | 133.94 | Upgrade
|
| Selling, General & Admin | 155.8 | 218.97 | 591.45 | 273.23 | 122.84 | 63.76 | Upgrade
|
| Research & Development | 121.03 | 141.42 | 388.36 | 132.74 | 69.93 | 36.96 | Upgrade
|
| Other Operating Expenses | 16.93 | 1.41 | 59.79 | 12.8 | 5.53 | -1.29 | Upgrade
|
| Operating Expenses | 423.85 | 446.93 | 1,403 | 439.59 | 204.57 | 100.15 | Upgrade
|
| Operating Income | -169.38 | -7.11 | 5,135 | 1,683 | 544.56 | 33.79 | Upgrade
|
| Interest Expense | -9.79 | -10.5 | -3.42 | -2.11 | -0.65 | - | Upgrade
|
| Interest & Investment Income | 110.73 | 124.94 | 52.85 | 12.36 | 6.18 | 7.75 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.22 | 1.22 | 21.52 | -3.13 | -1.44 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.41 | 4.88 | -7.46 | -1.08 | -0.39 | 5 | Upgrade
|
| EBT Excluding Unusual Items | -53.82 | 113.42 | 5,199 | 1,689 | 548.26 | 46.56 | Upgrade
|
| Gain (Loss) on Sale of Investments | 5.23 | 4.59 | 2.76 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.8 | 0.31 | 0.01 | - | 0.15 | -0 | Upgrade
|
| Asset Writedown | -74.35 | -38.02 | -147.03 | - | - | - | Upgrade
|
| Other Unusual Items | 125.91 | 59.59 | 22.02 | 5.69 | 8.29 | - | Upgrade
|
| Pretax Income | 3.77 | 139.89 | 5,076 | 1,695 | 556.7 | 46.55 | Upgrade
|
| Income Tax Expense | 54.86 | 70.67 | 695.84 | 247.87 | 81.07 | 4.05 | Upgrade
|
| Earnings From Continuing Operations | -51.08 | 69.22 | 4,381 | 1,447 | 475.63 | 42.51 | Upgrade
|
| Minority Interest in Earnings | 61.65 | 5.71 | -172.06 | -33.46 | -6.7 | -0.98 | Upgrade
|
| Net Income | 10.56 | 74.93 | 4,208 | 1,413 | 468.93 | 41.53 | Upgrade
|
| Net Income to Common | 10.56 | 74.93 | 4,208 | 1,413 | 468.93 | 41.53 | Upgrade
|
| Net Income Growth | -97.95% | -98.22% | 197.79% | 201.37% | 1029.25% | -32.39% | Upgrade
|
| Shares Outstanding (Basic) | 228 | 227 | 228 | 212 | 209 | 208 | Upgrade
|
| Shares Outstanding (Diluted) | 228 | 227 | 230 | 212 | 209 | 208 | Upgrade
|
| Shares Change (YoY) | -1.04% | -1.22% | 8.61% | 1.43% | 0.23% | 17.77% | Upgrade
|
| EPS (Basic) | 0.05 | 0.33 | 18.46 | 6.68 | 2.25 | 0.20 | Upgrade
|
| EPS (Diluted) | 0.05 | 0.33 | 18.31 | 6.68 | 2.25 | 0.20 | Upgrade
|
| EPS Growth | -97.93% | -98.20% | 174.19% | 197.11% | 1026.62% | -42.59% | Upgrade
|
| Free Cash Flow | -65.06 | 282.52 | 3,699 | 1,023 | 331.4 | -9.45 | Upgrade
|
| Free Cash Flow Per Share | -0.29 | 1.24 | 16.09 | 4.84 | 1.59 | -0.04 | Upgrade
|
| Dividend Per Share | 0.150 | 0.120 | 3.490 | 2.027 | 0.643 | 0.032 | Upgrade
|
| Dividend Growth | -93.96% | -96.56% | 72.18% | 214.98% | 1898.45% | -85.70% | Upgrade
|
| Gross Margin | 72.87% | 58.68% | 62.09% | 75.00% | 78.11% | 73.94% | Upgrade
|
| Operating Margin | -48.50% | -0.95% | 48.77% | 59.47% | 56.78% | 18.65% | Upgrade
|
| Profit Margin | 3.02% | 10.00% | 39.97% | 49.94% | 48.89% | 22.92% | Upgrade
|
| Free Cash Flow Margin | -18.63% | 37.69% | 35.13% | 36.17% | 34.55% | -5.22% | Upgrade
|
| EBITDA | -86.95 | 59.3 | 5,180 | 1,704 | 561.8 | 50.56 | Upgrade
|
| EBITDA Margin | -24.90% | 7.91% | 49.19% | 60.22% | 58.58% | 27.91% | Upgrade
|
| D&A For EBITDA | 82.44 | 66.41 | 45.04 | 21.28 | 17.24 | 16.78 | Upgrade
|
| EBIT | -169.38 | -7.11 | 5,135 | 1,683 | 544.56 | 33.79 | Upgrade
|
| EBIT Margin | -48.50% | -0.95% | 48.77% | 59.47% | 56.78% | 18.65% | Upgrade
|
| Effective Tax Rate | 1454.21% | 50.52% | 13.71% | 14.63% | 14.56% | 8.69% | Upgrade
|
| Revenue as Reported | 349.23 | 749.54 | 10,530 | 2,830 | 959.1 | 181.16 | Upgrade
|
| Advertising Expenses | - | 12.13 | 56.66 | 23.94 | 6.97 | 4.98 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.